C4's An­drew Hirsch blows up IPO to $182M, while on­colyt­ic virus up­start nabs $87M of­fer­ing

On Fri­day, Mass­a­chu­setts-based biotechs C4 Ther­a­peu­tics and On­corus be­came the lat­est to jump on­to Nas­daq.

Less than a month af­ter be­ing tapped as C4 Ther­a­peu­tics’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER